Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MORPHOSYS : From a Buy to Neutral rating by JP Morgan

06/11/2021 | 02:01am EDT

The analyst James Gordon from JP Morgan has published a research note on the case. Initially a Buy, the broker is now neutral. The target price is reduced from EUR 105 to EUR 80.


© MarketScreener with dpa-AFX Analyser 2021
All news about MORPHOSYS AG
06/17CONSTELLATION PHARMACEUTICALS  : RBC Capital Downgrades Constellation Pharmaceut..
MT
06/17MORPHOSYS  : Commences Cash Tender Offer for All Outstanding Shares of Constella..
PU
06/16MORPHOSYS  : Commences Cash Tender Offer for All Outstanding Shares of Constella..
PU
06/16PRESS RELEASE  : MorphoSys Commences Cash Tender -2-
DJ
06/16PRESS RELEASE  : MorphoSys Commences Cash Tender Offer for All Outstanding Share..
DJ
06/16MORPHOSYS  : Commences Cash Tender Offer for All Outstanding Shares of Constella..
EQ
06/16European ADRs Flat in Wednesday Morning Trading
MT
06/16MORPHOSYS  : Berenberg reaffirms its Buy rating
MD
06/14European ADRs Move Higher in Monday Trading
MT
06/11SECTOR UPDATE : Health Care Stocks Roughed Up Heading into Friday Close
MT
More news
Financials
Sales 2021 180 M 214 M 214 M
Net income 2021 -198 M -236 M -236 M
Net cash 2021 647 M 771 M 771 M
P/E ratio 2021 -11,5x
Yield 2021 -
Capitalization 2 217 M 2 642 M 2 641 M
EV / Sales 2021 8,75x
EV / Sales 2022 4,91x
Nbr of Employees 609
Free-Float 96,8%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 110,29 €
Last Close Price 67,68 €
Spread / Highest target 132%
Spread / Average Target 63,0%
Spread / Lowest Target 12,3%
EPS Revisions
Managers and Directors
NameTitle
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Malte Peters Chief Research & Development Officer
Roland Wandeler Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
MORPHOSYS AG-27.86%2 642
MODERNA, INC.93.81%81 297
LONZA GROUP AG15.68%53 313
IQVIA HOLDINGS INC.37.47%47 206
CELLTRION, INC.-25.07%32 426
SEAGEN INC.-12.42%27 835